Sunfox Technologies has raised $7 million, around Rs. 67 crore, in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital.

The Dehradun-based medtech startup plans to use the money to expand its portable cardiac diagnostics platform, Spandan. Its larger aim is simple but important – bring heart testing closer to patients, especially in places where specialist healthcare is difficult to access.

What Sunfox Technologies does

Sunfox began as a research and development venture in Uttarakhand in 2016. It was founded by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola.

The founders started exploring healthcare technology after losing a friend during their college years. Their work eventually led to Spandan, a portable ECG platform that can connect with a smartphone.

An ECG records the electrical activity of the heart. Doctors use it to study heart rhythm and identify warning signs that may require urgent medical attention.

Spandan is designed for homes, clinics, hospitals, telemedicine networks and public-health centres. A healthcare worker can record a patient’s ECG and share it with a doctor or cardiologist for remote review.

This can be especially useful in rural locations. A patient may not need to travel immediately to a large city for an initial heart assessment. A local health worker can capture the ECG and seek expert guidance from a district hospital or remote-care network.

The purpose of the $7 million funding

The new capital will support Sunfox’s next stage of growth. The company plans to expand its presence across India, hire more employees, strengthen research and development and build international sales and distribution capabilities.

Sunfox is also working toward regulatory clearances in the United States and Europe. Its products already have approvals in India, Ghana, Kenya, Tanzania and South Africa, according to the company’s press release received.

The startup says around 60,000 Spandan devices have been deployed across India and have reached more than 20,000 villages. The platform has been used in clinics, homes and public-health programmes.

Sunfox will also invest in clinical evidence, engineering and new cardiac technologies. These steps are important as the company enters global markets with strict medical-device requirements.

Why Spandan is different

Traditional ECG machines are usually found in hospitals and larger clinics. They can be expensive, bulky and difficult to move. Spandan focuses on portability and smartphone connectivity.

The company’s official product information describes Spandan as a compact ECG system capable of producing digital reports that can be shared with doctors.

Its model combines medical hardware, software and remote doctor support. That combination can help connect frontline health workers with specialists without requiring every patient to visit a major hospital.

However, a portable ECG does not replace emergency care or a qualified doctor. Anyone experiencing severe chest pain, breathing difficulty or other serious symptoms should seek immediate medical attention.

Competition and future plans

Sunfox competes with established ECG manufacturers, telemedicine platforms and remote cardiac-monitoring companies. Its difference lies in combining portable ECG hardware with smartphone-based reporting and remote interpretation.

The company also became widely known after receiving investment from all five investors on the first season of “Shark Tank India”. The latest Series A round could help Sunfox grow from an Indian medtech startup into a global cardiac-care technology company.

Conclusion with key takeaways

Sunfox Technologies has raised $7 million to scale its Spandan portable ECG platform.

The funds will support Indian expansion, international market entry, hiring, research and regulatory approvals.

Spandan aims to make cardiac testing more portable and accessible for homes, clinics and rural healthcare centres.

The company’s biggest opportunity is to reduce delays in initial heart assessment while building a trusted India-made healthcare technology brand.

Recent funding announcements show how varied India’s startup ecosystem has become. Investors are backing businesses in lab-grown diamonds, enterprise AI, kitchen products, developer tools and primary healthcare.

The five companies are solving very different problems. ONYA is making diamond jewellery more accessible, Ema is building AI employees for large companies, Curaa is designing products for Indian kitchens, ByteAsk is creating coding agents for C and C++, and MyRx is building digital infrastructure for primary care.

ONYA raises Rs. 12.5 crore for lab-grown diamond jewellery

Lab-grown diamond jewellery startup ONYA has raised Rs. 12.5 crore in a pre-Series A round led by Divisa Family Office. Existing investor Zeropearl VC also participated. The company had earlier raised Rs. 5.5 crore in seed funding.

Founded by Himani Yadav and Gaurav Choudhary, ONYA operates stores in Bengaluru, Pune and Hyderabad.

The company said it has reached monthly recurring revenue of Rs. 3.5 crore within 20 months of launch. ETRetail reported that the new capital will be used for more stores, digital customer acquisition, personalization, product design and manufacturing research.

ONYA’s difference lies in its focus on contemporary designs and technology-led production. It highlights its patented ONYA Setting and uses IGI-certified lab-grown diamonds with BIS-hallmarked gold. Unlike traditional jewellers that mainly depend on large physical networks, ONYA is combining retail stores with online discovery and customization.

Its competition includes other lab-grown diamond brands and established jewellery companies entering the same category. The challenge will be building trust, explaining the value of lab-grown diamonds and maintaining strong product quality as the market grows.

Ema raises $77 million for AI employees

Enterprise AI company Ema has raised $77 million in Series B funding led by Creaegis. Existing investors Accel, S32 and Prosus also joined the round. The funding takes Ema’s total capital raised to $140 million.

Ema was founded in 2023 by Surojit Chatterjee and Souvik Sen.

Its main product is a group of AI employees that can handle work in areas such as human resources, IT and finance. Instead of only answering questions, these AI systems are designed to complete multi-step tasks across the software that a company already uses.

For example, an AI employee could receive an IT request, check company rules, update the right system and inform the employee about the result. This is different from a basic chatbot that simply gives a written reply.

Ema says its technology already supports large enterprise workloads. At Wipro, its employee assistant supports more than 240,000 associates across 65 countries and handles millions of queries and workflows. The company says the new funding will help it expand the use of AI employees in production environments. Ema’s funding announcement describes its focus on HR, IT and finance operations.

Ema competes with enterprise automation platforms and other agentic AI companies. Its key selling point is the attempt to complete work from start to finish, with less manual coordination.

Curaa gets Rs. 40 crore to build better kitchen products

Kitchen and lifestyle brand Curaa has raised Rs. 40 crore in Series A funding led by 3one4 Capital. Kae Capital, Lumikai and Better Capital also participated.

Curaa was founded in 2024 by chef and content creator Sanjyot Keer and entrepreneur Neeraj Kumawat.

The company develops kitchen appliances and tools based on Indian cooking habits. Its funding will support product development, branding, supply chain improvements and expansion across online and offline channels. ET reported that Curaa wants to build a wider omnichannel presence.

Curaa’s advantage is its connection with cooking content and practical Indian kitchen needs. A mixer, storage product or cooking tool designed for Indian recipes may need different features from products created for western kitchens.

The company competes with established appliance brands and newer direct-to-consumer kitchenware businesses. Its next test will be maintaining quality and customer service while expanding its product range.

ByteAsk raises $1 million for specialized coding agents

AI coding startup ByteAsk has raised $1 million in pre-seed funding from Y Combinator, Entrepreneur First and angel investors connected to global trading firms.

Founded in 2026 by Anirudha Kulkarni and Pratyush Saini, ByteAsk is focused on C and C++ development.

These languages are widely used in cars, chips, operating systems and trading systems.

ByteAsk’s main difference is that it does not stop after generating code. Its agent builds, tests and debugs changes using real compilers, debuggers and testing tools. This matters because a small error in low-level software can cause performance, security or safety problems.

The company plans to use its early capital to improve the product, expand its developer base and build tools for businesses that depend on systems-level software. Y Combinator describes ByteAsk as an AI coding agent that can work through the terminal, code editors and on-premise systems.

Its competitors include general-purpose AI coding assistants. ByteAsk is taking a narrower path by focusing on languages where accuracy and testing are especially important.

MyRx raises undisclosed seed funding for primary care

Healthcare technology company MyRx has raised an undisclosed seed round led by SteerX VC.

The Hyderabad-based company was co-founded in 2019 by Sourav Das, Surjit Das and Neel Rath.

MyRx describes itself as a primary healthcare infrastructure company. Its platform brings together doctor networks, teleconsultation, electronic prescriptions, electronic medical records and patient engagement tools.

The company plans to use the funding to expand its clinical network and strengthen the technology needed to deliver doctor-led primary care at scale. Malik Times reported that the amount of the round was not disclosed.

MyRx is different from a simple online doctor-booking app. Its focus is on the systems that help doctors, clinics, hospitals and healthcare brands manage consultations and follow-up care. It competes with digital clinics, telehealth platforms and healthcare software providers.

Conclusion and key takeaways

These five funding rounds reflect five different startup opportunities. ONYA is trying to modernize jewellery buying, Ema is moving AI from demonstrations into daily company operations, Curaa is bringing creator-led thinking to kitchen products, ByteAsk is targeting difficult software development work, and MyRx is building the digital backbone for primary care.

The common thread is specialization. Each company is focusing on a clear customer problem instead of trying to serve everyone at once.

Key takeaways –

• ONYA raised Rs. 12.5 crore for lab-grown diamond jewellery expansion.
• Ema raised $77 million to scale AI employees across enterprise functions.
• Curaa raised Rs. 40 crore for product development and kitchen brand expansion.
• ByteAsk raised $1 million to build specialized C and C++ coding agents.
• MyRx raised an undisclosed seed round to expand primary healthcare infrastructure.
• All five startups are trying to stand apart through focused products and industry-specific solutions.

Butterfly Learnings has raised Rs. 65 crore in a Pre-Series B funding round, giving the paediatric behavioural health startup fresh capital to expand its work in child therapy, developmental care and early autism screening.

The round was led by Inflexor Ventures. Existing investors Enzia Ventures, Insitor Impact Asia Fund and IIMA Ventures also took part in the funding round, according to reports.

This is an important development in India’s healthtech space because Butterfly Learnings works with children who need support for autism, ADHD, learning disabilities and other developmental or behavioural challenges. For many parents, early signs are visible at home, but getting the right screening, diagnosis and therapy support can still be difficult. Butterfly Learnings wants to make that journey easier and more organized.

What Butterfly Learnings does

Butterfly Learnings is a Maharashtra-based digital health startup focused on paediatric behavioural healthcare. It was founded by Dr. Sonam Kothari and Dr. Abhishek Sen.

The startup brings together therapy, diagnostics, inclusive education, digital therapeutics and technology-led interventions under one model. In simple words, it is not only running therapy centres. It is trying to build a full care system where children can be screened, guided, treated and supported over time.

Its services are mainly meant for children who may need help with communication, behaviour, learning, social skills or daily-life development. This can include children with autism, ADHD, speech delays or learning difficulties.

For example, if a child is not responding to their name, has delayed speech or finds social interaction difficult, the family may need screening first. After that, the child may need therapy, parent guidance and regular progress tracking. Butterfly Learnings is building its model around this full journey.

Purpose of the Rs. 65 crore funding

The new funding will be used for three main areas – expanding centres, building AI and technology capabilities, and scaling autism screening.

Butterfly Learnings currently has 90 centres across 22 cities in India, as per the report. With the fresh capital, the startup plans to grow its physical presence beyond Maharashtra.

This is useful because child therapy is still highly location-dependent. Online support can help in some cases, but many children need in-person sessions with trained therapists. More centres can reduce travel pressure for families and make regular therapy more practical.

The startup also plans to invest in AI and other technology tools. In healthcare, AI should not be seen as a replacement for doctors or therapists. Its better role is to support screening, documentation, progress tracking and decision-making, while trained professionals continue to guide the child’s care.

Focus on Get SET Early

A key part of Butterfly Learnings’ expansion plan is Get SET Early, its eye-tracking-based autism screening solution.

According to reports, Butterfly Learnings has an exclusive global licence for this technology. The solution has received approval from CDSCO and can be used to screen children from one year of age.

This matters because early screening can help families act sooner. If developmental concerns are identified early, parents can seek therapy and guidance at the right time instead of waiting for school-age struggles to become more visible.

Butterfly Learnings does not plan to keep this screening only inside its own centres. The company wants to make it available through hospitals and paediatricians as well. That could bring screening closer to normal child healthcare visits.

Why early screening matters

Many parents first notice small signs. A child may avoid eye contact, not speak at the expected age, repeat certain actions, struggle with instructions or find it hard to play with other children.

These signs do not always mean a child has autism or another condition. But they do mean the child may benefit from proper screening. Early screening helps parents avoid guesswork.

If Get SET Early reaches hospitals and paediatricians, more families may get access to screening during routine medical visits. That can be especially helpful for parents who do not know where to begin.

Therapist training will also get attention

Butterfly Learnings also runs a therapist training institute. The company plans to expand this programme as it grows.

This is a practical move because India needs more trained professionals in child behavioural healthcare. Opening more centres is not enough if there are not enough skilled therapists to run them.

Therapy quality depends heavily on training, supervision and consistency. A good therapist does not only spend time with the child. They also observe behaviour, set small goals, work with parents and adjust the plan as the child improves.

For families, better therapist training can mean more reliable care and clearer progress.

Competitors and market overview

Butterfly Learnings operates in a growing but still under-served market. Its competition includes child development centres, therapy clinics, hospitals, mental health platforms and special education providers.

In related areas, names such as Continua Kids, Mom’s Belief, Lissun, Amaha, Children First and Ummeed Child Development Center are active in child development, mental health or therapy-led care.

Butterfly Learnings’ main strength appears to be its mix of physical centres, technology-enabled screening, therapy services, inclusive education and therapist training. Still, this is a sensitive sector. Long-term trust will depend on quality of care, trained staff, affordability and visible outcomes for families.

Conclusion with key takeaways

Butterfly Learnings’ Rs. 65 crore Pre-Series B funding is a meaningful update for India’s digital health and child development space. The startup is not only expanding therapy centres, but also putting money behind early autism screening, AI-led tools and therapist training.

If the plan works well, more families may get access to early screening and structured therapy closer to home. For parents, that can mean less confusion and faster support during a child’s early years.

Key takeaways –

1. Butterfly Learnings has raised Rs. 65 crore in Pre-Series B funding.
2. The round was led by Inflexor Ventures.
3. Enzia Ventures, Insitor Impact Asia Fund and IIMA Ventures also participated.
4. The startup was founded by Dr. Sonam Kothari and Dr. Abhishek Sen.
5. It currently has 90 centres across 22 cities in India.
6. The funding will support centre expansion, AI tools, autism screening and therapist training.
7. A major focus will be Get SET Early, its eye-tracking-based autism screening solution.

Facts Input- Digital Health News